Filtern
Volltext vorhanden
- ja (30)
Gehört zur Bibliographie
- ja (30)
Dokumenttyp
Sprache
- Englisch (30)
Schlagworte
- heart failure (6)
- myocardial infarction (5)
- cytokines (3)
- echocardiography (3)
- inflammation (3)
- GFAP (2)
- acute heart failure (2)
- anxiety (2)
- cardiac magnetic resonance imaging (2)
- chronic heart failure (2)
- depression (2)
- heart (2)
- left ventricular ejection fraction (2)
- mortality (2)
- natriuretic peptide (2)
- neurofilament light chain (2)
- ARDS (acute respiratory distress syndrome) (1)
- ATP generation (1)
- Alzheimer’s dementia (1)
- Bioluminescence (1)
- Brain atrophy (1)
- CD4+ T-cells (1)
- COVID-19 (1)
- COVID‐19 vaccination (1)
- Ca2+i handling (1)
- Cardiac dysfunction| Brain natriuretic peptide (1)
- CardioMEMS™ HF-System (1)
- Chronic heart failure (1)
- Chronic heart-failure (1)
- Cognitive decline (1)
- GMPcGMP-dependent protein kinase I (1)
- Germany (1)
- Glial fibrillary acidic protein (1)
- Heart failure (1)
- IP3 (1)
- Impella (1)
- MRI (1)
- Memory dysfunction (1)
- Mena/VASP (1)
- Mfn2 KO mice (1)
- NSG animals (1)
- NfL (1)
- Non‐ischaemic cardiogenic shock (1)
- Prevalence (1)
- Prognostic impact (1)
- Risk-factors (1)
- SARS‐CoV‐2 infection (1)
- SR/mitochondria metabolic feedback (1)
- ST-elevation myocardial infarction (1)
- STEMI (1)
- Stroke (1)
- T cells (1)
- Troponin (1)
- Valvular heart-desease (1)
- actin (1)
- adaptive immune response (1)
- age (1)
- aneurysm (1)
- anti-myocardial (1)
- anti‐SARS‐CoV‐2‐spike IgG (1)
- apoptosis (1)
- autoantibody (1)
- behavior (1)
- biomarkers (1)
- blood coagulation factor XIII (1)
- cancer treatment (1)
- cardiac hypertrophy (1)
- cardiac training group (1)
- cardiology (1)
- cardiovascular disease (1)
- cardiovascular magnetic resonance (1)
- cell staining (1)
- chronic distress (1)
- cognitive impairment (1)
- comprehensive psychosomatic assessment (1)
- cyclic (1)
- diastolic dysfunction (1)
- dilated cardiomyopathy (1)
- endothelin-1 (1)
- extracellular matrix (1)
- gene-environment interaction (1)
- glial damage (1)
- glial fibrillary acidic protein (1)
- healing and remodelling processes (1)
- health care (1)
- healthcare workers (1)
- heart failure training group (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- immune cells (1)
- immuno-modulation (1)
- immunosenescence (1)
- infarction size (1)
- inflammaging (1)
- intensive care medicine (1)
- ischemic stroke (1)
- left ventricular thrombusv (1)
- lymphocytes (1)
- m exercise training (1)
- metastasis (1)
- mice (1)
- mild (1)
- mitochondrial mRyR1 (1)
- mitofusin 2 (1)
- morbidity (1)
- myocardial aging (1)
- myocardium (1)
- neurology (1)
- neuroscience (1)
- neutrophils (1)
- pandemia (1)
- phosphorylated tau protein (1)
- prognosis (1)
- public health (1)
- pulmonary artery pressure (1)
- quality of life (1)
- randomized controlled trial (1)
- recovery (1)
- recurrent Tako-Tsubo cardiomyopathy (1)
- regulatory T cells (1)
- remote monitoring (1)
- renal function (1)
- right ventricular dysfunction (1)
- seroprevalence (1)
- serotonin transporter deficient mice (1)
- sex differences (1)
- spectrin (1)
- statins (1)
- systems biology (1)
- therapy (1)
- troponin (1)
Institut
- Medizinische Klinik und Poliklinik I (28)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (16)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (7)
- Neurologische Klinik und Poliklinik (4)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Institut für Virologie und Immunbiologie (3)
- Medizinische Klinik und Poliklinik II (3)
- Institut für Informatik (2)
- Institut für Pharmakologie und Toxikologie (2)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
Sonstige beteiligte Institutionen
Long-term sequelae in hospitalized Coronavirus Disease 2019 (COVID-19) patients may result in limited quality of life. The current study aimed to determine health-related quality of life (HRQoL) after COVID-19 hospitalization in non-intensive care unit (ICU) and ICU patients. This is a single-center study at the University Hospital of Wuerzburg, Germany. Patients eligible were hospitalized with COVID-19 between March 2020 and December 2020. Patients were interviewed 3 and 12 months after hospital discharge. Questionnaires included the European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L), patient health questionnaire-9 (PHQ-9), the generalized anxiety disorder 7 scale (GAD-7), FACIT fatigue scale, perceived stress scale (PSS-10) and posttraumatic symptom scale 10 (PTSS-10). 85 patients were included in the study. The EQ5D-5L-Index significantly differed between non-ICU (0.78 ± 0.33 and 0.84 ± 0.23) and ICU (0.71 ± 0.27; 0.74 ± 0.2) patients after 3- and 12-months. Of non-ICU 87% and 80% of ICU survivors lived at home without support after 12 months. One-third of ICU and half of the non-ICU patients returned to work. A higher percentage of ICU patients was limited in their activities of daily living compared to non-ICU patients. Depression and fatigue were present in one fifth of the ICU patients. Stress levels remained high with only 24% of non-ICU and 3% of ICU patients (p = 0.0186) having low perceived stress. Posttraumatic symptoms were present in 5% of non-ICU and 10% of ICU patients. HRQoL is limited in COVID-19 ICU patients 3- and 12-months post COVID-19 hospitalization, with significantly less improvement at 12-months compared to non-ICU patients. Mental disorders were common highlighting the complexity of post-COVID-19 symptoms as well as the necessity to educate patients and primary care providers about monitoring mental well-being post COVID-19.